Judge Rules For Andrx In Bristol-Myers Patent Suit Over Monopril
Andrx Corp. does not infringe a patent that Bristol-Myers Squibb Co. holds for its Monopril hypertension drug, a federal judge has ruled in a decision that clears the way for Andrx...To view the full article, register now.
Already a subscriber? Click here to view full article